Trial intelligence / Profile preview

Intraperitoneal Nebulised Local Anaesthetic in Laparoscopic Cholecystectomy

NCT00180687Phase 3Completed

Sponsor
Imperial College London
Start
Oct 2004
Primary completion
Sep 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of bupivacaine in postoperative pain (4 arms), sponsored by Imperial College London. Primary endpoint: Reduction in Postoperative Pain at 24 hours. Started Oct 2004; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00180687.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00180687.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call